MedSN, Inc., a leading medical education, sales training,
and marketing services provider based in the United States, today
announced that it has merged with the Indegene group of companies,
the preeminent medical education, training, and marketing services
provider in India and Asia. The combined companies will continue
to operate in the United States as Medsn, Inc.
The newly merged firms bring to the fore proven development and
delivery capabilities; a global talent pool exceeding 200, including
more than 60 physicians, pharmacists, and allied health care professionals;
and geographic coverage in the biggest and fastest-growing markets,
with offices in Los Angeles, Jersey City, Chicago, Philadelphia,
Bangalore, New Delhi, Mumbai, and Singapore. Medsn will now leverage
the capabilities of its global workforce to deliver unprecedented
quality in a timely and cost-effective manner to its pharmaceutical,
biotechnology, and medical device customers in the United States.
The merger will also significantly enhance Medsn’s ability
to support the launches of its customers’ products worldwide.
“As our customers continue to expand their global presence
in India and Asia,” says Dennis Bonilla, President and CEO
of Medsn, “our newly forged partnership with Indegene will
enable our firm to better address those customers’ strategic
needs. While some companies have initiated off-shoring partnerships,
this is the first and only example of two companies merging that
have similar go-to-market strategies, are both market leaders in
their geographies, and are both focused exclusively on one vertical,
healthcare. Medsn and Indegene have combined their expertise for
the past two years and have refined a delivery model that will significantly
improve value to our clients. We are now in a position to drive
global innovation, development, and delivery on a 24/7 basis to
support the key customer needs of quality, cost, and speed to market.
The combined teams of Indegene and Medsn, with their strong customer
relationships in their respective geographies, will provide a solid
foundation for growing a world-class company.”
“We are pioneering a unique model for providing medical education
and marketing services that will leverage delivery capabilities
and physician relationships from multiple geographies,” adds
Dr. Rajesh Nair, President and CEO of Indegene. “With a footprint
that currently spans the United States, Southeast Asia, and India,
the Indegene/Medsn combination is poised to fundamentally change
the dynamics of the industry.”
“We see this transaction as a key step toward establishing
a world-class pharmaceutical and medical device services firm,”
concludes Sriram Nadathur, Director of Nadathur Fareast, a leading
private equity firm and investor in Indegene Group. “The Medsn-Indegene
merger represents an important step in our plan to create a consortium
of global companies ranging from drug discovery to pharmaceutical
marketing that are dominant in their space. We believe that this
approach will allow us to generate significant value.”
Edgemont Capital Partners served as exclusive adviser to MedSN.
About Medsn
Medsn is a premier medical education and marketing company that
designs and implements customized interactive educational programs
for the pharmaceutical, medical device, biotechnology, and health
care industries. Medsn employs a multidisciplinary staff of physicians,
marketing experts, industry executives, medical illustrators, and
technology specialists — all with unique expertise in effectively
merging interactive multimedia technologies with traditional educational
methods — to develop high-impact programs that influence the
behavior of physicians and patients as well as pharmaceutical and
medical device sales representatives. The company is supported by
key academic advisers at leading institutions as well as by experts
in the fields of sales and marketing, communications, and learning.
For more information, visit www.medsn.com
About Indegene Group
Indegene is a global provider of knowledge-intensive services that
span a full spectrum of integrated scientific promotions, medical
education, and business analytical solutions for pharmaceutical,
medical device, and health care organizations. Indegene has offices
throughout India as well as subsidiaries in Singapore and the United
States. The firm boasts a highly specialized team of physicians
and medical professionals, content developers, analysts, brand managers,
and medical communication experts. Indegene’s pioneering global
delivery model for pharmaceutical services leverages its multi-geography,
multimarket advantage to deliver medical content and communication
services that provide significantly higher return on investment
and shorter delivery time for clients.
For more information, visit www.indegene.com
and www.indegeneusa.com
About Nadathur Group
Nadathur is a Bangalore, India–based private equity firm
established by N. S. Raghavan, Founder and Former Joint Managing
Director of Infosys (NASDAQ – INFY). Nadathur is focused on
the life sciences, aerospace/engineering services, and IT domains.
The firm supports a portfolio of more than 16 companies that are
engaged in leading-edge technologies, knowledge-intensive domains,
and IP creation. Through funding acquisitions and globalization
initiatives, the firm is building market-dominant consortia of companies.
Nadathur Fareast is the Singapore-based investment arm that facilitates
expansion (both organic and inorganic) of portfolio companies.
For more information, visit www.nadathur.com
Contact
Dennis Bonilla
Medsn, Inc.
310.253.7223
dennis.bonilla@medsn.com
Dr. Rajesh Nair
Indegene, Inc
703.946.1730
rajesh@indegene.com
David K. Blume
Managing Director
Edgemont Capital Partners
Phone: 212-867-8935 Fax: 212-214-0911
|
